Angela Dolganiuc, MD
Gastroenterology · Beckley, WVNPI 1316232317
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 32.8% of the total. Reporting peaked in 2019 at $457 and has fallen 85.8% since, to $65 in 2025. That places this record below the midpoint for gastroenterology clinicians in WV, where the typical reported total is $1,371.
Across 63 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$392
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$256
- Pfizer$120
- Takeda Pharmaceuticals U.S.A., Inc.$101
- Boston Scientific$91
- Bristol Myers Squibb$37
- plus $199 from 10 others
What the payments were for
- Food & beverage$1,15396%
- Education$303%
- Entertainment$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $392 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $256 |
| Pfizer | 3 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $101 |
| Boston Scientific | 1 | $91 |
| Bristol Myers Squibb | 2 | $37 |
| Ferring Pharmaceuticals Inc. | 1 | $30 |
| Ironwood Pharmaceuticals, Inc | 2 | $28 |
| Novo Nordisk | 1 | $26 |
| Gilead | 2 | $24 |
| Redhill Biopharma Inc. | 1 | $19 |
| Braintree Laboratories, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Sanofi | 1 | $15 |
| Mauna Kea Technologies, Inc. | 1 | $12 |
| Echosens North America, Inc. | 1 | $11 |
How this compares
$1,196 in reported general payments places this provider in the 45th percentile of 72 gastroenterology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 32 | $288,143 |
| XifaxanRifaximin | 42 | $159,729 |
| LinzessLinaclotide | 89 | $103,108 |
| CreonLipase/Protease/Amylase | 18 | $63,899 |
| IbsrelaTenapanor Hcl | 20 | $44,867 |
| Dexlansoprazole DrDexlansoprazole | 41 | $12,598 |
| Sucralfate | 184 | $9,215 |
| Famotidine | 592 | $8,516 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 42 | $6,624 |
| Colestipol Hcl | 38 | $5,052 |
| Scopolamine | 26 | $4,863 |
| Omeprazole | 282 | $4,537 |
| Pantoprazole Sodium | 255 | $4,374 |
| Rabeprazole Sodium | 29 | $3,815 |
| Lactulose | 72 | $2,710 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon | $392 | $167,007107 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $256 | $159,72942 claims |
| Braintree Laboratories, Inc.Sutab | $18 | $6,62442 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 72 gastroenterology providers in West Virginia.
Other gastroenterology in Beckley
- Sardar Shah-KhanBeckley$27K
- Richard MaillouxBeckley$6K
- Charles Bou-AbboudBeckley$1K
- Husam NazerBeckley$1K
- Touraj FaridBeckley$311
- Jennifer VeverkaMorgantown$283K
- Shailendra SinghMorgantown$187K
- Mohamad HaffarSouth Charleston$118K
- Shyam ThakkarMorgantown$113K
- Hazem Al-AshhabParkersburg$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.